Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2003
05/07/2003EP1307550A1 Human 7tm protein receptors and polynucleotides encoding the same
05/07/2003EP1307549A2 Methods and compositions for diagnosing and treating chromosome-18p related disorders
05/07/2003EP1307537A1 Neospora caninum isolate
05/07/2003EP1307489A2 G protein-coupled receptors
05/07/2003EP1307488A2 A human calcium channel protein and uses thereof
05/07/2003EP1307487A2 Regulation of human calcium-independent alpha-latro-toxin-like g protein-coupled receptor
05/07/2003EP1307486A2 Somatostatin analogues
05/07/2003EP1307485A1 Peptide mimetics
05/07/2003EP1307484A1 Potential growth factors from the human tumour cell line ht1080
05/07/2003EP1307483A2 Iapl-3 a protein inhibitor of apoptosis proteins
05/07/2003EP1307482A2 Two coloured fluorimetric protease assay
05/07/2003EP1307481A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression
05/07/2003EP1307480A2 Mutant trichosanthin
05/07/2003EP1307478A2 Novel nucleotide sequences coding for the luxr gene and a process for the production of l-amino acids
05/07/2003EP1307477A2 Nucleotide sequences which code for the metf gene
05/07/2003EP1307476A1 Nucleotide sequences which code for the mete gene
05/07/2003EP1307474A2 Proton-translocating retinal protein
05/07/2003EP1307473A1 Purification of hbv antigens for use in vaccines
05/07/2003EP1307240A2 Radiolabelled metal transport protein as imaging agent
05/07/2003EP1307234A2 Methods for treatment of hyperproliferative diseases using human mda-7
05/07/2003EP1307222A2 Non-human animal models of tolerance to hepatitis c virus immunogens
05/07/2003EP1307219A2 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof
05/07/2003EP1307216A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
05/07/2003EP1307215A2 I-superfamily conotoxins
05/07/2003EP1307214A1 Highly homogeneous molecular markers for electrophoresis
05/07/2003EP1307212A2 Plant derived antioxidants
05/07/2003EP1307211A1 Immune mediators and related methods
05/07/2003EP1307098A1 METHODS FOR BLOCKING RESISTANCE TO Bt TOXINS IN INSECTS AND NEMATODES
05/07/2003EP1272512A4 Immunokine composition and method
05/07/2003EP1223968B1 Use of urodilatin for treating chronic kidney failure with residual kidney functions
05/07/2003EP1143996B1 Use of a bpi protein for the preparation of a medicament for treating chronic cardiac disease
05/07/2003EP1029039A4 Non-transgenic animal model of alzheimer's disease
05/07/2003EP1007705B1 Sugarcane bacilliform virus promoter
05/07/2003EP0957943B1 Matrix-free osteogenic devices, implants and methods of use thereof
05/07/2003EP0836648B1 Recombinant mva virus, and the use thereof
05/07/2003EP0762889B1 Heparin-binding protein for the treatment of sepsis
05/07/2003EP0742720B1 Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production
05/07/2003EP0729784B1 Method of absorbing interleukins
05/07/2003EP0722737B1 Use of HGF for the preparation of a medicament against CNS disorders
05/07/2003EP0683234B1 Antibody against beta-amyloid or their derivative and use thereof
05/07/2003EP0682699B1 FUNCTIONAL DOMAINS IN $i(FLAVOBACTERIUM OKEANOKOITES) (FOKI) RESTRICTION ENDONUCLEASE
05/07/2003EP0674526B1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease
05/07/2003EP0672138B1 Chimeric procoagulant proteins
05/07/2003EP0669982B1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins
05/07/2003CN1416471A Recombinant rhabdoviruses as Live-Viral vaccines for immunodoeficiency viruses
05/07/2003CN1416467A Zinc finger domains and methods of identifying same
05/07/2003CN1416461A Bacillus subtilis Var. chungkookjang producing high molecular weight poly-gumma-glutamic acid
05/07/2003CN1416354A Vascular endothelial growth factor 2
05/07/2003CN1416350A Novel method for down-regulation of amyloid
05/07/2003CN1416348A Modified factor VIII
05/07/2003CN1415750A Proteinic coded sequence of agglutinin of grand crinum and its application
05/07/2003CN1415628A Method for extracting luteinizing hormone from human urine
05/07/2003CN1415626A Method for preparing peptide of tussur silk
05/07/2003CN1107681C Compound of polypeptide as antigen of hepatitis B virus and heat shock protein and its application
05/07/2003CN1107521C Method for reducing viscosity of pathological mucoid airway contents in respiratoy tract
05/07/2003CA2405849A1 Reagents for the simultaneous detection of hcv core antigens and antibodies
05/06/2003US6560542 Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins
05/06/2003US6559359 Plant extression vector for use as efficient gene transfer tool in genetic engineering
05/06/2003US6559358 Generation of plants with delayed flowering; obtain plant, transform with expression vector, express nucleotide sequences, propagate plant compare flowering with control
05/06/2003US6559357 Modulating cell proliferation in plants; obtain plant, transform, express vector containing modulator of cell proliferation, monitor adjustment in size and gene expresson in transformed plants, compare to control
05/06/2003US6559354 Transcription and gene expression regulators
05/06/2003US6559298 Polypeptides that bind interleukin-18 (IL-18)
05/06/2003US6559295 Mycobacterium fol A gene that encodes for the enzyme dihydrofolate reductase
05/06/2003US6559294 Chlamydia pneumoniae polynucleotides and uses thereof
05/06/2003US6559290 Isolation of chemokine; obtain sample, incubate with styrene-divinylbenzene copolymers, recover chemokine
05/06/2003US6559288 Ninjurin
05/06/2003US6559287 Artificial glycoprotein for use in the treatment of immunological, arthritic, asthmatic, psoriasis, chronic obstructive pulmonary disorders, inflammatory bowel, osteoarthritic and viral disorders
05/06/2003US6559286 Antibodies for use in the diagnosis and treatment of cancer
05/06/2003US6559285 Antibody for use in the treatment of cancer
05/06/2003US6559284 Process for purifying a protein
05/06/2003US6559282 Induction of antibodies against leutenizing hormone releasing hormone in mammals; obtain mammal, administer modulator, monitor immune response, evaluate for prevention of infections
05/06/2003US6559281 Non-naturally occurring synthetic lytic peptides
05/06/2003US6559280 Controlling protein levels in eucaryotic organisms
05/06/2003US6559279 Process for preparing peptide derivatized oligomeric compounds
05/06/2003US6559176 A method for regulating the activity of an autoinducer-2 receptor comprising contacting an autoinducer-2 receptor with an AI-2 agonist or antagonist compound.
05/06/2003US6559128 Peptide blocks the site of binding between a G protein and a G protein coupled receptor in a cell
05/06/2003US6559126 Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
05/06/2003US6559124 Use of prosaposin and peptides obtained therefrom for treatment of neural degeneration
05/06/2003US6559123 Compositions to inhibit the growth of epithelial cells or heal a wound or treat a burn consisting of the chromatographically recovered polypeptide
05/06/2003US6559121 Vaccines for the protection of cattle from psoroptic scabies
05/06/2003US6559120 Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
05/06/2003US6559119 Biomedical device intended for implantation into an animal's body and having a supplemented tissue sealant composition applied to at least a portion of at least one surface thereof
05/06/2003US6558953 Grapevine leafroll virus proteins and their uses
05/06/2003US6558952 Expansion of preferential pancreatic cells; generate nutrient broth, inoculate with pancreatic cells and gastrin receptor ligand, monitor propagation of pancreatic cells
05/06/2003US6558950 Nucleotide sequences coding polypeptide for use in the treatment of programed cell death defects
05/06/2003US6558932 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
05/06/2003US6558926 Method for production of tetanus toxin using media substantially free of animal products
05/06/2003US6558925 Stem cell inhibitor
05/06/2003US6558924 Recombinant expression of insulin C-peptide
05/06/2003US6558920 High expression system of proteins
05/06/2003US6558918 Nucleic acid that encode a cell growth regulatory protein
05/06/2003US6558913 Detection of preferential genotype in humans; obtain sample, incubate with probe, evaluate for homo/heterozygosity, evaluate for blood disorder
05/06/2003US6558912 Screening for modulators of apoptosis; obtain cells containing apoptosis polypeptide, incubate with binding protein, expose to modulator, monitor concentration of bound protein in presence of modulator, compare to control
05/06/2003US6558910 SF, a novel family of taste receptors
05/06/2003US6558898 Antibody for use in the treatment of viral diseases
05/06/2003US6558687 Fibrin polymer structure
05/06/2003US6558677 Native outer membrane vesicles having outer membrane proteins and lipopolysaccharides from neisseria genetically altered so that neisseria is unable to synthesize sialic acid
05/06/2003US6558676 Immunizing mammal with noninfectious material and isolating antibodies produced
05/06/2003US6558675 Mutant human hepatitis B viral strain and uses thereof
05/06/2003US6558674 Polynucleotide vaccine formulation against pathologies of the horse